Autoscriber, an Amsterdam-based startup that is developing an AI-based voice recognition software, raised an undisclosed amount of funding in its pre-Seed round led by LUMO labs.
Healthcare professionals can access Autoscriber as a subscription-based software-as-a-service (SaaS) solution for large hospitals and practices, smaller practices, and general practitioners. And this raised capital will enable Autoscriber to go live in multiple hospitals during the next 12 months.
Company: Autoscriber B.V.
Raised: undisclosed amount
Funding Month: September 2021
Lead Investors: LUMO labs
Company Website: https://www.autoscriber.com/
Software Category: AI-based voice recognition software
About the Company: Founded this year in June (2021) by Jacqueline Kazmaier and Koen Bonenkamp, Autoscriber develops AI-powered speech recognition and natural language processing technologies to extract structured data from conversations between physicians and patients. The technology was developed in collaboration with the Clinical Artificial Intelligence and Research Lab (CAIRELab) at Leiden University Medical Center. With this software, Autoscriber aims to reduce the administrative burden on medical professionals, free up time to spend caring better for patients, and enhance capabilities along the entire healthcare supply chain.